Black Diamond Therapeutics Inc Earnings

The next earnings date for Black Diamond Therapeutics Inc is November 10, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Black Diamond Therapeutics Inc Earnings

Report Date	Estimated Earnings Per Share
11/10/2025	$-0.22

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Black Diamond Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/12/2025	---	$-0.19	22.98%
05/07/2025	Before Market	$0.98	484.31%
03/10/2025	Before Market	$-0.28	10.17%
11/04/2024	Before Market	$-0.28	25.59%
08/06/2024	Before Market	$-0.36	7.69%
05/09/2024	Before Market	$-0.35	18.60%
03/12/2024	Before Market	$-0.34	27.66%
11/06/2023	Before Market	$-0.45	8.16%
08/11/2023	Before Market	$-0.52	3.70%
05/09/2023	Before Market	$-0.57	6.56%
03/09/2023	Before Market	$-0.59	6.35%
11/08/2022	Before Market	$-0.60	6.25%
08/09/2022	Before Market	$-0.63	7.35%
05/11/2022	After Market	$-0.70	6.67%
03/17/2022	After Market	$-0.71	29.70%
11/08/2021	Before Market	$-0.97	1.02%
08/12/2021	Before Market	$-0.95	-13.10%
05/07/2021	Before Market	$-0.84	-23.53%
03/25/2021	Before Market	$-0.63	0.00%
11/10/2020	Before Market	$-0.50	3.85%
08/11/2020	Before Market	$-0.41	6.82%
05/12/2020	Before Market	$-0.51	-6.25%
03/24/2020	Before Market	$-4.63	-237.96%
10/07/2019	---	$-0.11	---

More About Black Diamond Therapeutics Inc

Website

https://www.blackdiamondtherapeutics.com

Country

USA

Full Time Employees

Black Diamond Therapeutics, Inc., a clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company's lead product candidate is BDTX-1535, a brain-penetrant epidermal growth factor receptor MasterKey inhibitor, which is in Phase 2 clinical trial for the treatment of epidermal growth factor receptor mutant non-small cell lung cancer, as well as Phase 1 clinical trial to treat glioblastoma. It is also developing BDTX-4933, a brain-penetrant RAF MasterKey inhibitor targeting KRAS, NRAS, and BRAF alterations in solid tumors that is in Phase 1 clinical trial. In addition, the company is developing BDTX-4876, a MasterKey inhibitor of oncogenic FGFR2/3 mutations with selectivity versus FGFR1/4, which is in preclinical stage. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

“Black Diamond Therapeutics Inc Earnings” Can Refer to the Black Diamond Therapeutics Inc Earnings Date

Some people say “Black Diamond Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Black Diamond Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Black Diamond Therapeutics Inc Stock on the Earnings Date

If you own Black Diamond Therapeutics Inc stock (BDTX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Black Diamond Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Black Diamond Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Black Diamond Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Black Diamond Therapeutics Inc earnings or anything else related to the stock market.